Latest Headlines

  1. Asimov Announces Cell Line Development Partnership With Ottimo Pharma To Accelerate Cancer Immunotherapy's Path To Clinic 8/27/2025

    Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced a cell line development partnership with Ottimo Pharma, a biopharmaceutical company developing first-in-class, one-of-a-kind PD1/VEGFR2 dual pathway antibodies to extend the lives of people living with cancer.

  2. Europharma Installs MES Software From Korber To Replace Manual Processes 8/22/2025

    Eurofarma Laboratórios has successfully transitioned all of its manufacturing operations at the main production facility in Itapevi, São Paulo to Körber’s PAS-X Manufacturing Execution System – becoming the first national company in Brazil to do so. The implementation paves the way to operational excellence, enabling real-time data access, full traceability, and enhanced regulatory compliance.

  3. Particle Measuring Systems Opens New Manufacturing & Innovation Hub To Drive Future Growth In Colorado 8/19/2025

    Particle Measuring Systems is proud to announce the opening of its new state-of-the-art Manufacturing & Innovation Hub, marking a major milestone in the company’s evolution and long-term growth and investment strategy. This purpose-built facility is designed to support innovation, enhance customer engagement and service delivery, and expand manufacturing capabilities—solidifying our leadership in advancing contamination-free manufacturing and sterility assurance.

  4. CDMO Made Scientific Opens New Cell Therapy Manufacturing Facility In New Jersey 8/14/2025

    Made Scientific, a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO), held a ribbon-cutting ceremony yesterday to commemorate the grand opening of its new 60,000 sq. ft. GMP manufacturing facility and headquarters in Princeton, New Jersey.

  5. Late Model Lab Equipment Auction: Assets Formerly Of Apertor 8/12/2025

    Federal Equipment Company, in conjunction with Heritage Global Partners, is hosting a global online auction featuring late-model lab and analytical equipment formerly of Apertor, an innovative Bay Area biotech company.

  6. Advancing Countermeasures Against Ebola And Deadly Viruses 8/12/2025

    Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, has been selected by BARDA's Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) to lead a project focused on "Manufacturing Optimization for Filovirus Human Monoclonal Antibodies."

  7. Meissner Announces New Rotary Impeller Mixing Solutions (RMS) Portfolio To Elevate Biocontainer Mixing Performance 8/11/2025

    Meissner is proud to announce the launch of its RMS (Rotary Impeller Mixing Solutions) portfolio, engineered to redefine reliability and performance in biocontainer mixing for bioprocessing. This innovative product line addresses the growing demand among biomanufacturers for robust, highquality mixing with the added assurance of supply chain security and dependable partnership.

  8. Repligen Opens Training & Innovation Center To Elevate Customer Experience 8/7/2025

    Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of its Repligen Training & Innovation Center (“RTIC”) at its Waltham headquarters.

  9. Minaris Advanced Therapies Opens New Manufacturing Facility In Germany 8/6/2025

    Minaris Advanced Therapies, a leading global contract development and manufacturing organization and testing provider, has announced the opening of its new GMP manufacturing facility in Munich, Germany.  The facility, located in Taufkirchen, strengthens Minaris' global manufacturing network and reinforces its position as a trusted partner in advancing cutting-edge therapies from concept to commercialization.

  10. Bora Pharmaceuticals Announces Multi-Year Expansion For Midwest Manufacturing Site, As Upsher-Smith Entity Split Is Finalized 8/5/2025

    Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”), a global leader in pharmaceutical manufacturing, has announced plans for significant investments to expand its manufacturing and packaging capabilities at its facility in Maple Grove, Minnesota.